ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 245 filers reported holding ALKERMES PLC in Q2 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $508,000 | -56.2% | 10,000 | -50.0% | 0.09% | -58.0% |
Q2 2017 | $1,159,000 | -34.0% | 20,000 | -33.3% | 0.22% | -34.2% |
Q1 2017 | $1,755,000 | -47.4% | 30,000 | -50.0% | 0.33% | -49.8% |
Q4 2016 | $3,335,000 | +18.2% | 60,000 | 0.0% | 0.66% | +13.5% |
Q3 2016 | $2,822,000 | +8.8% | 60,000 | 0.0% | 0.58% | +6.0% |
Q2 2016 | $2,593,000 | +12.8% | 60,000 | 0.0% | 0.55% | +12.7% |
Q1 2016 | $2,299,000 | -51.7% | 60,000 | 0.0% | 0.49% | -49.9% |
Q4 2015 | $4,763,000 | +35.3% | 60,000 | 0.0% | 0.98% | +28.4% |
Q3 2015 | $3,520,000 | -8.8% | 60,000 | 0.0% | 0.76% | +1.3% |
Q2 2015 | $3,860,000 | +5.5% | 60,000 | 0.0% | 0.75% | +6.4% |
Q1 2015 | $3,658,000 | +4.1% | 60,000 | 0.0% | 0.71% | +2.9% |
Q4 2014 | $3,514,000 | +36.6% | 60,000 | 0.0% | 0.69% | +30.9% |
Q3 2014 | $2,572,000 | -14.8% | 60,000 | 0.0% | 0.52% | -12.4% |
Q2 2014 | $3,020,000 | +14.2% | 60,000 | 0.0% | 0.60% | +9.9% |
Q1 2014 | $2,645,000 | – | 60,000 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |